NorthWest Biotherapeutics Inc (NWBO)

[iwasadiver]

I contacted NICE regarding what they formally did. My response via email was this and I'm awaiting further emails:

Thank you for contacting the National Institute for Health and Care Excellence (NICE) regarding our proposed topic for a technology appraisal for Glioblastoma Multiforme (newly diagnosed)- DCVax-L. Your inquiry has been passed on to the corporate communications team to respond.

I can confirm that we are considering Glioblastoma Multiforme (newly diagnosed)-DCVax-L as a possible topic for guidance to the NHS. The Department of Health will make a decision on whether to formally refer this topic to NICE in due course. If we recieve a formal referral, we will programme the topic into our appraisal schedule as quickly as we can, but I'm unable to be specific about the timescales for doing so at this stage.

Technology appraisals are recommendations on the use of new and existing medicines and treatments within the NHS.

These can be:
medicines
medical devices
diagnostic techniques
surgical procedures
health promotion activities

NICE is asked to look at particular drugs and devices when the availability of the drug or device varies across the country.

Kind regards,

Katy

Katy Summerscales
Communications Executive
National Institute for Health and Care Excellence